Librero Jiménez, MartaHeredia Carrasco, ClaraFernández Cano, María Del Carmen2023-05-032023-05-0320221130-0108http://hdl.handle.net/10668/21700Nintedanib is a multikinase inhibitor used for the treatment of pulmonary idiopathic fibrosis. We present the first report published to date of severe hepatotoxicity and jaundice secondary to nintedanib.enChemical and Drug Induced Liver InjuryHumansIdiopathic Pulmonary FibrosisIndolesSevere hepatotoxicity secondary to nintedanib.research article33371696open access10.17235/reed.2020.7585/2020https://doi.org/10.17235/reed.2020.7585/2020